The pharmaceutical industry on Thursday refuted Karnataka Chief Minister Siddaramaiah’s remarks linking COVID-19 vaccines ...

Top doctors, industry experts, and pharma leaders refute Karnataka CM's claim linking Covid-19 vaccines to sudden deaths, ...

The prevalence of irritable bowel syndrome and constipation rose significantly during the COVID-19 pandemic, highlighting the ...

Pharma promoters may be competing fiercely in the market, but on Thursday they all rallied behind domestically- manufactured ...

The GOP House Intelligence Committee Chairman is critiquing the Trump CIA director's review of the Intelligence Community's assessment on Russian meddling in the 2016 election ...

When the first reports of a new COVID-19 variant emerge, scientists worldwide scramble to answer a critical question: Will ...

The FDA's Dr. Vinay Prasad said that he disagreed with the agency's career vaccine reviewers about COVID shot approvals.

SARS-CoV-2 infection in children and adolescents increases risk for cardiovascular disease, compared with uninfected individuals.

FDA vaccines chief Vinay Prasad limited broader use of COVID vaccines, citing reduced risk and data concerns. Read more here.

The 2023 to 2024 COVID-19 vaccine provided additional effectiveness against medically attended COVID-19, according to a study published online June 24 in JAMA Network Open. Ruth Link-Gelles, Ph.D., M.

The firm is seeking marketing clearance for its Liaison NES real-time PCR instrument along with a multiplex test for flu A/B, COVID-19, and respiratory syncytial virus infection.

In patients with COVID-19, preexisting immunity and Omicron infection were associated with reduced disease severity and upper respiratory symptom presentation.